IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Carcinoma
Interventions:   Radiation: Intensity modulated radiotherapy;   Drug: Cisplatin
Sponsor:   Nanfang Hospital of Southern Medical University
Not yet recruiting - verified September 2016

http://ift.tt/2m3lOLI